Conclusion Age is not the taboo of radical mastectomy, and elderly patients benefit from adjuvant endocrine therapy for more.

结论年龄并不是乳腺癌根治术的禁忌，且老年患者从辅助内分泌治疗中获益较多。

youdao

In the U. S, minorities and women under 40 and over 80 frequently don't receive adjuvant endocrine therapy (AET) for breast cancer, putting their lives at risk, researchers say.

在美国，研究人员称少数裔及40岁以下、80岁以上乳腺癌女性患者不经常接受内分泌辅助治疗，存在生存风险。

youdao